Rütgen Barbara C, Wolfesberger Birgitt, Baumgartner Daniel, Hammer Sabine E, Groiss Sandra, Hittmair Katharina M, Gradner Gabriele, Fuchs-Baumgartinger Andrea, Donovan Taryn A, Schwendenwein Ilse
Clinical Pathology, Department of Biological Sciences and Pathobiology, University of Veterinary Medicine Vienna, Vienna, Austria.
Clinical Unit of Internal Medicine Small Animals, Department for Companion Animals and Horses, University of Veterinary Medicine Vienna, Vienna, Austria.
Front Vet Sci. 2024 May 28;11:1378826. doi: 10.3389/fvets.2024.1378826. eCollection 2024.
Gastrointestinal lymphoma is the most common form of lymphoma in domestic cats. Aggressive phenotypes are much less common but do bear and unfavorable prognosis. Immunophenotyping by flow cytometry (FCM) is not systematically performed in these patients, because of difficulties in the acquisition of suitable sample material from the gastrointestinal tract. A multimodal diagnostic approach is recommended to improve identification of subtypes targeting patient tailored therapeutic strategies. The aim of this prospective study was to present results of multicolor FCM immunophenotyping in surgically removed gastrointestinal mass and relate them with histopathology using the World Health Organization (WHO) classification and clonality PCR testing. Thirty-two patients were included. Eight cats (25%) had gastric, 23 (72%) had intestinal lymphoma and 1 (3%) had gastric/jejunal lymphoma. Intestinal lymphoma sites were represented by 18 small intestinal, 4 ileocaecal, 1 large intestinal. All gastric lymphomas were diffuse large B-cell lymphoma (DLBCL). Small intestinal lymphomas were 10 enteropathy associated T-cell lymphoma type I (EATL I), 2 enteropathy associated T-cell lymphoma type II (EATL II), 2 peripheral T-cell lymphoma (PTCL), 3 DLBCL and one DLBCL+EATL II. The most common small intestinal FCM T-cell phenotype was CD3CD21 CD4CD8CD18 CD5CD79 in 7/10 EATL I and one EATL II. The most frequent FCM B-cell phenotype was CD3CD21 CD4CD8CD18 CD5CD79 in 13/17 DLBCL and the DLBCL+EATL II. Clonality PCR results were positive in 87.5% (28/32) of all cases. No cross-lineage rearrangement was observed. IHC and FCM results agreed in 87.5% (28/32) of all cases. When all 3 methods were combined, consistent results were seen in 75% (24/32). This is the first demonstration of a multicolor FCM approach set in context to the gold standard histopathology and clonality testing results.
胃肠道淋巴瘤是家猫中最常见的淋巴瘤形式。侵袭性表型较为少见,但预后不佳。由于难以从胃肠道获取合适的样本材料,这些患者未系统地进行流式细胞术(FCM)免疫表型分析。建议采用多模式诊断方法,以更好地识别亚型,制定针对患者的治疗策略。这项前瞻性研究的目的是展示手术切除的胃肠道肿物的多色FCM免疫表型分析结果,并将其与使用世界卫生组织(WHO)分类和克隆性PCR检测的组织病理学结果相关联。纳入了32例患者。8只猫(25%)患有胃淋巴瘤,23只(72%)患有肠淋巴瘤,1只(3%)患有胃/空肠淋巴瘤。肠淋巴瘤的部位包括18例小肠、4例回盲部、1例大肠。所有胃淋巴瘤均为弥漫性大B细胞淋巴瘤(DLBCL)。小肠淋巴瘤包括10例I型肠病相关T细胞淋巴瘤(EATL I)、2例II型肠病相关T细胞淋巴瘤(EATL II)、2例外周T细胞淋巴瘤(PTCL)、3例DLBCL和1例DLBCL+EATL II。在7/10的EATL I和1例EATL II中,最常见的小肠FCM T细胞表型为CD3CD21 CD4CD8CD18 CD5CD79。在13/17的DLBCL和DLBCL+EATL II中,最常见的FCM B细胞表型为CD3CD21 CD4CD8CD18 CD5CD79。所有病例中87.5%(28/32)的克隆性PCR结果为阳性。未观察到跨谱系重排。免疫组化(IHC)和FCM结果在所有病例的87.5%(28/32)中一致。当三种方法联合使用时,75%(24/32)的结果一致。这是首次将多色FCM方法与金标准组织病理学和克隆性检测结果相结合的展示。